By: D. Verhoeven MD, PhD, F. Neckebroeck MD, B. Dullens MD, W. Demey MD, K. Sandelin MD, PhD, A. Jager MD, PhD
Breast cancer care is a costly health issue in Europe where efficacy depends on early detection and equitable access to treatment options. Yet, inequities persist and must be addressed. With a better strategy we could do more with less, providing value-based cancer care with a focus on patient-centred research.
(BELG J MED ONCOL 2025;19(4): 151–156)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
